MITOCHONDRIAL CAPACITY, MUSCLE ENDURANCE, AND LOW ENERGY IN FRIEDREICH ATAXIA

被引:14
作者
Bossie, Hannah M. [1 ]
Willingham, T. Bradley [1 ]
Van Schoick, Robbi A. [1 ]
O'Connor, Patrick J. [1 ]
McCully, Kevin K. [1 ]
机构
[1] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30605 USA
关键词
affect; disease severity; fatigability; fatigue; mechanomyography; near-infrared spectroscopy; non-invasive measurements; IRON REGULATORY PROTEIN-1; PERFORMANCE; FATIGUE; SUPPLEMENTATION; CARBOHYDRATE; SPECTROSCOPY; FRATAXIN; DEFICIT;
D O I
10.1002/mus.25524
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction: In this study we noninvasively evaluated skeletal muscle mitochondrial capacity, muscle-specific endurance, and energy/fatigue feelings in persons with Friedreich ataxia (FRDA) and able-bodied controls (AB). Methods: Forearm mitochondrial capacity was measured in FRDA (n = 16) and AB (n = 10) study participants using the rate of recovery of oxygen consumption after electrical stimulation with near-infrared spectroscopy. Mechanomyography (MMG) assessed muscle endurance after electrical stimulation for 3 minutes at 2 Hz, 4 Hz, and 6 Hz. Validated scales assessed disease severity and energy/fatigue feelings. Results: Groups did not differ in mitochondrial capacity (FRDA and AB: 1.8 0.3 L/min). The difference in muscle endurance at 6 Hz was lower by 19.2% in the FRDA group (group effect: P < 0.001). Feelings of physical energy were 34% lower in FRDA group. In FDRA muscle, endurance was positively related to mitochondrial capacity (r = 0.59, P = 0.03), and disease severity was negatively related to mitochondrial capacity (r = -0.55, P = 0.04) and muscle endurance (r = -0.60, P = 0.01). Conclusion: Non-invasive measures of skeletal muscle mitochondrial capacity and muscle-specific endurance are useful in monitoring FRDA.
引用
收藏
页码:773 / 779
页数:7
相关论文
共 37 条
  • [1] Effects of 6 Weeks of Quercetin Supplementation on Energy, Fatigue, and Sleep in ROTC Cadets
    Bigelman, Kevin A.
    Chapman, Donald P.
    Freese, Eric C.
    Trilk, Jennifer L.
    Cureton, Kirk J.
    [J]. MILITARY MEDICINE, 2011, 176 (05) : 565 - 572
  • [2] Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia
    Bradley, JL
    Blake, JC
    Chamberlain, S
    Thomas, PK
    Cooper, JM
    Schapira, AHV
    [J]. HUMAN MOLECULAR GENETICS, 2000, 9 (02) : 275 - 282
  • [3] Monitoring progression in Friedreich ataxia (FRDA): the use of clinical scales
    Buerk, Katrin
    Schulz, Stefanie R.
    Schulz, Joerg B.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2013, 126 : 118 - 124
  • [4] The tools of disability outcomes research functional status measures
    Cohen, ME
    Marino, RJ
    [J]. ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2000, 81 (12): : S21 - S29
  • [5] Collin C, 1988, Int Disabil Stud, V10, P61
  • [6] Fatigue is frequent and multifactorial in Friedreich's ataxia
    da Silva, Cynthia B.
    Chevis, Camila F.
    D'Abreu, Anelyssa
    Lopes-Cendes, Iscia
    Franca, Marcondes C., Jr.
    [J]. PARKINSONISM & RELATED DISORDERS, 2013, 19 (08) : 766 - 767
  • [7] Effects of consumption of sucromalt, a slowly digestible carbohydrate, on mental and physical energy questionnaire responses
    Dammann, Kristen W.
    Bell, Margie
    Kanter, Mitch
    Berger, Alvin
    [J]. NUTRITIONAL NEUROSCIENCE, 2013, 16 (02) : 83 - 95
  • [8] Dogan I, ANN CLIN TRANSL NEUR
  • [9] Health related quality of life measures in Friedreich Ataxia
    Epstein, Elizabeth
    Farmer, Jennifer M.
    Tsou, Amy
    Perlman, Susan
    Subramony, S. H.
    Gomez, Christopher M.
    Ashizawa, Tetsuo
    Wilmot, George R.
    Mathews, Katherine
    Wilson, Robert B.
    Balcer, Laura J.
    Lynch, David R.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2008, 272 (1-2) : 123 - 128
  • [10] Skeletal muscle oxidative capacity in patients with cystic fibrosis
    Erickson, Melissa L.
    Seigler, Nichole
    McKie, Kathleen T.
    McCully, Kevin K.
    Harris, Ryan A.
    [J]. EXPERIMENTAL PHYSIOLOGY, 2015, 100 (05) : 545 - 552